Specialty medical injectable drug program, requirements and drug policy updates: Byooviz™

Please review the following table to determine changes to our specialty medical injectable drug programs.

Specialty medical injectable drugs added to review at launch
Drug Name UnitedHealthcare Commercial Treatment Uses


X Indicated for the treatment of patients with Neovascular (Wet) Age-Related Macular Degeneration, Macular Edema Following Retinal Vein Occlusion, and Myopic Choroidal Neovascularization. 

Review the UnitedHealthcare Commercial Plan Review at Launch Medication List. 

For questions, please contact your broker or UnitedHealthcare representative.

More updates for your business

New releases, updates and notifications for a broad spectrum of UnitedHealthcare products and services.

Important, required notices for products, plans, forms and more.

Need-to-know operational announcements for you and your employees.